Group 1 - The US IPO market experienced a quiet week due to the Thanksgiving holiday, with two blank check companies going public and several others filing initial applications [1][3] - Soulpower Acquisition announced a merger with SWB Holdings, with a proposed valuation of $8.1 billion, marking one of the largest merger announcements of the year [1] - Two SPACs completed pricing, with Invest Green Acquisition raising $150 million and SC II Acquisition also raising $150 million, both focusing on renewable energy [1] Group 2 - Three SPACs filed for initial public offerings, including Mountain Lake Acquisition II aiming to raise $261 million, Vine Hill Capital II targeting $175 million, and Social Commerce Partners seeking $100 million [2] - Edison Oncology Holding submitted an IPO application to raise $25 million, while Direct Communications Solutions aims to raise $15 million [1][2] - The IPO market is expected to remain relatively calm at the beginning of December, with no pricing plans for the upcoming week, although some issuers may still complete pricing before year-end [3] Group 3 - Medline is anticipated to be a focal point in the IPO market, with an expected raise of $5 billion, which would be the largest IPO in the US since 2021 [3][4] - Other notable potential listings include Klook, Grayscale, and York Space Systems, which have recently submitted preliminary applications [4] - Companies like Hornbeck Offshore Services, Cardinal Infrastructure, and Andersen Group have updated their prospectuses and may go public before the end of the year [4]

Core Points - SC II Acquisition Corp. successfully closed its initial public offering (IPO) of 17,250,000 units at a price of $10.00 per unit, generating gross proceeds of $172,500,000 [1] - The units began trading on the Nasdaq Global Market under the symbol "SCIIU" on November 26, 2025 [1] - Each unit consists of one Class A ordinary share and one right to receive one-fifth of a Class A ordinary share upon the completion of the initial business combination [1] Private Placement - Concurrently with the IPO, the Company closed a private placement of 255,000 units at $10.00 per unit, resulting in gross proceeds of $2,550,000 [2] - The private placement units are identical to those sold in the IPO, with certain limited exceptions [2] Company Overview - The Company is a blank check company formed to pursue mergers, amalgamations, share exchanges, asset acquisitions, share purchases, reorganizations, or similar business combinations [3] - It may target initial business combinations in any industry or geographical location [3] - The Company's sponsor is managed by Nukkleus Defense Technologies, Inc., a wholly-owned subsidiary of Nukkleus Inc, with Menny Shalom as the CEO [3] Offering Management - D. Boral Capital acted as the sole book-running manager for the offering [4] - Legal counsel for the Company was provided by Ellenoff Grossman & Schole LLP and Appleby (Cayman) Ltd., while Loeb & Loeb LLP served as legal counsel to the underwriters [4]

Core Points - Nukkleus, Inc. has successfully closed its initial public offering (IPO) for SC II Acquisition Corp, a special purpose acquisition company, where Nukkleus is the majority owner of the sponsor [1][2] - SC II raised gross proceeds of $172.5 million through the sale of units at an offering price of $10.00 per unit, including an additional $22.5 million from underwriters for over-allotments [2] - Each unit consists of one Class A ordinary share and one right to receive one fifth of a Class A ordinary share upon the completion of a business combination [2] Company Overview - Nukkleus focuses on acquiring and scaling mission-critical suppliers in the defense, aerospace, and advanced manufacturing sectors, targeting Tier 2 and Tier 3 companies [6] - The company aims to modernize and expand strategic suppliers, supporting dual-use innovation and resilient supply chains through its proprietary capital model [6] - Nukkleus combines organic growth with disciplined mergers and acquisitions (M&A) to achieve transformational scale and position itself at the core of the 21st-century defense industrial strategy [7]

Core Viewpoint - Nukkleus, Inc. is strategically acquiring and developing businesses in the aerospace and defense industry, with the announcement of the initial public offering (IPO) of its special purpose acquisition company, SC II Acquisition Corp. [1] Group 1: Initial Public Offering Details - SC II aims to raise gross proceeds of $150 million through the sale of units priced at $10.00 each, with each unit consisting of one Class A ordinary share and a right to receive one fifth of a Class A ordinary share upon a business combination [2] - The underwriters have an option to purchase an additional $22.5 million of units in the IPO, which is expected to close on or about November 28, 2025 [2] - SC II units will be listed on the Nasdaq Global Market under the symbol "SCIIU" [2] Group 2: Sponsorship and Management - SC Capital II Sponsor LLC, an indirect subsidiary of Nukkleus, is acting as the sponsor of SC II, with Nukkleus holding a majority interest [3] - The CEO of Nukkleus, Menachem Shalom, also serves as the CEO of SC II [3] Group 3: Company Overview - Nukkleus focuses on acquiring and scaling mission-critical suppliers in the defense, aerospace, and advanced manufacturing sectors, targeting Tier 2 and Tier 3 companies that are essential to national security infrastructure in the U.S., Israel, and Europe [7] - The company employs a portfolio approach that combines organic growth with disciplined mergers and acquisitions (M&A), positioning itself at the core of 21st-century defense industrial strategy [8]

Core Viewpoint - SC II Acquisition Corp. has announced the pricing of its initial public offering (IPO) of 15,000,000 units at a price of $10.00 per unit, with trading set to begin on November 26, 2025 [1] Company Overview - The Company is a blank check company formed to pursue a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses across any industry or geographical location [2] - The Company's sponsor is managed by Nukkleus Defense Technologies, Inc., a wholly-owned subsidiary of Nukkleus Inc, with Menny Shalom serving as the Chief Executive Officer and director [2] Offering Details - The IPO consists of 15,000,000 units, each comprising one Class A ordinary share and one right to receive one fifth (1/5) of a Class A ordinary share upon the completion of the initial business combination [1] - The offering is expected to close on November 28, 2025, subject to customary closing conditions [1] - D. Boral Capital is the sole book-running manager for the offering, with legal counsel provided by Ellenoff Grossman & Schole LLP and Appleby (Cayman) Ltd. [3] Additional Information - The Company has granted underwriters a 45-day option to purchase up to an additional 2,250,000 units at the IPO price to cover over-allotments [3] - A registration statement for the units and underlying securities became effective on November 25, 2025 [4]